Despite the volatility in broader equities this year, investing in stocks remains wise, as holding shares of leading companies for five years often yields superior returns. In the biotech sector, two companies to consider are CRISPR Therapeutics (NASDAQ: CRSP) and Regeneron Pharmaceuticals (NASDAQ: REGN), both of which have experienced significant share declines over the past year but may offer substantial upside for patient investors. This highlights the importance of long-term investment strategies, even during uncertain periods.
